DeepScribe
About
Specialty-focused ambient AI medical documentation platform with the highest KLAS score in the category (98.8 in 2025 First Look report). DeepScribe's AI is trained specifically for specialty workflows — cardiology, orthopedics, oncology, psychiatry — with specialty-specific terminology, note formats, and coding recommendations. Includes automated E/M coding that analyzes the note and recommends the appropriate billing code. Enterprise-only deployment (no self-serve); bidirectional EHR sync with...
Details
VenSearch Intelligence
Ideal Customer
- DeepScribe's sweet spot is large group specialty practices, multi-location cancer care networks, and enterprise health systems — particularly those with active oncology programs or value-based care contracts.
- Notable enterprise customers include Ochsner Health (4,700 clinicians across 46 hospitals), Texas Oncology, Florida Cancer Specialists, and New York Cancer & Blood Specialists.
Key Differentiators
- DeepScribe's primary differentiator is its specialty-first AI architecture — unlike generalist ambient scribes, its models are trained per specialty on clinical data from complex encounters in oncology, cardiology, urology, and others, giving it a meaningful data moat that generalist competitors cannot easily replicate.
- The company earned a 98.8 KLAS performance score (highest in the ambient AI documentation category for 2025) and A+ ratings across all six measured KLAS categories, plus Top 5 placement in three Quadruple Aim categories at the 2025 KLAS Emerging Solutions Top 20 event.
Industries Served
- DeepScribe serves exclusively the healthcare industry, with a laser focus on clinical documentation for physician practices and health systems.
- Their deepest vertical is oncology — they report that organizations using their platform see approximately 40% of all cancer care visits in the U.S. — followed by cardiology, gastroenterology, neurology, orthopedics, and urology.
Service Coverage
- DeepScribe operates exclusively within the United States healthcare market, with no publicly disclosed international commercial deployments.
- The platform is deployed across more than 2,800 clinics and health systems nationwide, with particular concentration in community oncology networks.
Partnerships
- DeepScribe has established several high-profile strategic technology partnerships.
- In January 2025, Flatiron Health named DeepScribe its first ambient AI partner, integrating with their OncoEMR system to serve 4,200+ oncology providers across 800+ community cancer care locations.
Company Size & Ownership
- DeepScribe was founded in 2017 by Matthew Ko, Akilesh Bapu, and Kairui Zeng, and is headquartered in San Francisco, CA.
- The company has approximately 101–133 employees as of mid-2025, reflecting growth from the 51–100 range cited in earlier filings.
Compliance & Certifications
- DeepScribe publicly declares full HIPAA compliance and signs standard Business Associate Agreements (BAAs) with covered entities, which is required for any healthcare vendor handling Protected Health Information (PHI).
- Their security practices page highlights AES-256 encryption for data in transit and at rest, redundant infrastructure, and ongoing employee HIPAA training.
Compiled from public sources by VenSearch · Last researched October 14, 2026
Offerings
1 offeringDeepScribe Ambient AI Documentation
Specialty-trained ambient AI documentation — highest KLAS performance score (98.8, 2025) in the ambient documentation category. AI learns individual physician documentation style and adapts note structure to specialty workflows. Automated E/M coding recommendation reduces billing manual review burden. Bidirectional EHR sync pushes completed notes into Epic, athenahealth, and eClinicalWorks without copy-paste.
Considering DeepScribe?
Our team will work with you to determine if DeepScribe is the right fit for your organization. From research and assessment through procurement negotiation and ongoing vendor management — we handle the entire process at no cost to you.